Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 112Leukemia, Lymphocytic, Chronic, B-Cell 111Leukemia 102Myelodysplastic Syndromes 101Precursor Cell Lymphoblastic Leukemia-Lymphoma 80Lymphoma 77Lymphoma, Non-Hodgkin 73Multiple Myeloma 69Hodgkin Disease 67Lymphoma, Follicular 55Lymphoma, Mantle-Cell 52Leukemia, Myelogenous, Chronic, BCR-ABL Positive 51Myeloproliferative Disorders 50Congenital Abnormalities 47Lymphoma, Large B-Cell, Diffuse 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Accelerated Phase 43Leukemia, Myeloid, Chronic-Phase 42Burkitt Lymphoma 41Leukemia, Myelomonocytic, Chronic 40Blast Crisis 33Primary Myelofibrosis 32Lymphoma, Large-Cell, Immunoblastic 30Waldenstrom Macroglobulinemia 29Neoplasms, Plasma Cell 29Melanoma 29Anemia, Refractory, with Excess of Blasts 29Recurrence 27Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 25Myelodysplastic-Myeloproliferative Diseases 24

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Clofarabine 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Metabolic Diseases × fludarabine phosphate × Clear all
NCT01596699 2020-02-26

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

University of California, San Francisco

Phase 2 Terminated
16 enrolled 11 charts

Bone Marrow Failure Disorders, Metabolic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡